Vera Therapeutics Inc - Class A —— 资产负债表 (NASDAQ:VERA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 83.75 M131.44 M175.55 M655.68 M734.73 M 负债总额 14.16 M54.53 M73.86 M78.53 M130.21 M 权益总额 69.59 M76.91 M101.69 M577.15 M604.52 M 负债及股东权益总额 83.75 M131.44 M175.55 M655.68 M734.73 M 总债务 13.92 M31.29 M53.71 M54.64 M77.31 M 净债务 -66.62 M-83.42 M-107.01 M-586.21 M-637.28 M

新闻

国信证券：IgAN治疗药物远期市场规模广阔认为Povetacicept具有BIC潜质

Wolfe Research基于估值上调Vera Therapeutics股票评级

Wolfe Research upgrades Vera Therapeutics stock rating on valuation

美国银行证券重申Vera Therapeutics股票买入评级

Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities

Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Vera Therapeutics任命Christopher Hite为董事会成员

Vera Therapeutics adds Christopher Hite to board of directors

3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com

Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)

VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg

礼来前高管Matt Skelton晋升为Vera Therapeutics首席商务官